Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma

Journal of Urology

Volumn 155, Issue 1, 1996, Pages 111-114

  Sengeløv, Lisa ^a   Kamby, Claus ^b   Von Der Maase, Hans ^b  

^a Mental Health Services CPH   (Denmark)

^b NONE

Author keywords

Bladder neoplasms; Carcinoma; Kidney neoplasms; Lymph nodes; Neoplasm metastasis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLADDER CANCER; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; FEMALE; HUMAN; HUMAN TISSUE; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

AGE FACTORS; AGED; BLADDER NEOPLASMS; BONE NEOPLASMS; CARCINOMA, TRANSITIONAL CELL; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0029655491     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199601000-00041     Document Type: Article

References (22)

1. Prout, G. R., Jr., Griffin, P. P. and Shipley, W. U.: Bladder carcinoma as a systemic disease. Cancer, 43: 2532, 1979.
2. Havsteen, H., von der Maase, H., Strøyer, I. and Rasmussen, F.: Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma. Cancer Treat. Rep., 71: 1285, 1987.
3. Sengeløv, L., Kamby, C., Schou, G. and von der Maase, H.: Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract. Cancer, 74: 123, 1994.
4. Bartolucci, A. A.: Estimation and comparison of proportions. In: Cancer Clinical Trials. Methods and Practice. Edited by M. E. Buyse, M. J. Staquet and R. J. Sylvester. New York: Oxford University Press, chapt. 20, pp. 337-360, 1984.
5. Kleinbaum, D. G., Kupper, L. L. and Morgenstern, H.: Epidemiologic Research. Principles and Quantitative Methods. New York: Van Nostrand Reinhold Company, 1982.
6. Logothetis, C. J., Dexeus, F. H., Finn, L., Sella, A., Amato, R. J., Ayala, A. G. and Kilbourn, R. G.: A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J. Clin. Oncol., 8: 1050, 1990.
7. Geertsen, P. F., Sengeløv, L., Larsen, S. K. and von der Maase, H.: A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium. Eur. J. Cancer, 29A: 347, 1993.
8. Loehrer, P. J., Sr., Einhorn, L. H., Elson, P. J., Crawford, E. D., Kuebler, P., Tannock, I., Raghavan, D., Stuart-Harris, R., Sarosdy, M. F. and Lowe, B. A.: A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J. Clin. Oncol., 10: 1066, 1992.
9. Sternberg, C. N., Yagoda, A., Scher, H. L, Watson, R. C., Geller, N., Herr, H. W., Morse, M. J., Sogani, P. C., Vaughan, E. D. and Bander, N.: Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer, 64: 2448, 1989.
10. Goldman, S. M., Fajardo, A. A., Naraval, R. C. and Medewell, J. E.: Metastatic transitional cell carcinoma from the bladder: radiographie manifestations. AJR, 132: 419, 1979.
11. Babaian, R. J., Johnson, D. E., Llamas, L. and Ayala, A. G.: Metastases from transitional cell carcinoma of urinary bladder. Urology, 16: 142, 1980.
12. Fetter, T. R., Bogaev, J. H., McCuskey, B. and Seres, J. L.: Carcinoma of the bladder: sites of metastases. J. Urol., 81: 746, 1959.
13. Cooling, C. I.: Review of 150 post-mortems of carcinoma of the urinary bladder. In: Tumours of the Bladder. Edited by D. M. Wallace. New York: Churchill Livingstone, pp. 171-185, 1959.
14. Friedell, G. H. and Mcauley, R. L.: Untreated bladder cancer: 31 autopsy cases. J. Urol., 100: 293, 1968.
15. Herr, H. W.: Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy. Urology, 25: 127, 1985.
16. Skinner, D. G.: Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J. Urol., 128: 34, 1982.
17. Timmer, P. R., Hartlief, H. A. and Hooijkaas, J. A.: Bladder cancer: pattern of recurrence in 142 patients. Int. J. Rad. Oncol. Biol. Phys., 11: 899, 1985.
18. Gospodarowicz, M. K., Hawkins, N. V., Rawlings, G. A., Connolly, J. G., Jewett, M. A. S., Thomas, G. M., Herman, J. G., Garrett, P. G., Chua, T., Duncan, W., Buckspan, M., Sugar, L. and Rider, W. D.: Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis. J. Urol., 142: 1448, 1989.
19. Greven, K. M., Solin, L. J. and Hanks, G. E.: Prognostic factors in patients with bladder carcinoma treated with definitive irradiation. Cancer, 65: 908, 1990.
20. Das, A. K., Carson, C. C., Bolick, D. and Paulson, D. F.: Primary carcinoma of the upper urinary tract. Effect of primary and secondary therapy on survival. Cancer, 66: 1919, 1990.
21. Batata, M. A., Chu, F. C., Hilaris, B. S., Kim, Y. S., Lee, M. Z., Chung, S. and Whitmore, W. F.: Factors of prognostic and therapeutic significance in patients with bladder cancer. Int. J. Rad. Oncol. Biol. Phys., 7: 575, 1981.
22. Wishnow, K. I. and Tenney, D. M.: Will Rogers and the results of radical cystectomy for invasive bladder cancer. Urol. Clin. N. Amer., 18: 529, 1991.